Stereotactic body radiation therapy for colorectal liver metastases

British Journal of Surgery

Volumn 97, Issue 3, 2010, Pages 377-382

  Van Der Pool, A E M ^a   Mendez Romero A ^a   Wunderink, W ^a   Heijmen, B J ^a   Levendag, P C ^a   Verhoef, C ^a   Ijzermans, J N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; RADIATION EXPOSURE; RADIATION INJURY; RADIOTHERAPY; STEREOTACTIC PROCEDURE;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY; STEREOTAXIC TECHNIQUES;

EID: 76649108554     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6895     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 2005; 23: 8490-8499.
3. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
4. de Meijer VE, Verhoef C, Kuiper JW, Alwayn IP, Kazemier G, IJzermans JN. Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 2006; 10: 960-973.
5. Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213.
6. Blomgren H, Lax I, Göranson H, Krsgmaeligpelien T, Nilsson B, Näslund I et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1998; 1: 63-74.
7. McGinn CJ, Ten Haken RK, Ensminger WD, Walker S, Wang S, Lawrence TS. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998; 16: 2246-2252.
8. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124: 1946-1955.
9. Dawson LA, Lawrence TS. The role of radiotherapy in the treatment of liver metastases. Cancer J 2004; 10: 139-144.
10. Herfarth KK, Debus J. [Stereotactic radiation therapy for liver metastases.] Chirurg 2005; 76: 564-569.
11. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007; 67: 793-798.
12. Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009; 27: 1585-1591.
13. WuIf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006; 45: 838-847.
14. Lax I, Blomgren H, Näslund I,Svansträm R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33: 677-683.
15. Méndez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol 2006; 45: 831-837.
16. Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol2006; 45: 848-855.
17. Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer2007; 109: 718-726.
18. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol2000; 7: 593-600.
19. Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009; 45: 1748-1756.
20. Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006; 141: 460-466.
21. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 1516-1522.
22. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27: 1579-1584.
23. Hoyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, Nellemann H et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006; 45: 823-830.
24. Dawson LA, McGinn CJ, Normolle D, Ten Haken RK, Walker S, Ensminger W et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18: 2210-2218.
25. Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol2007; 25: 1670-1676.
26. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol2004; 22: 229-237.
27. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1371-1378.
28. Wulf J, Hädinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177: 645-655.
29. Dois LF, Verhoef C, Eskens FA, Schouten O, Nonner J, Hop WC et al. [Improvement of 5 year survival rate after liver resection for colorectal metastases between 1984 and 2006.] Ned Tijdschr Geneeskd2009; 153: 490-495.
30. Verhoef C, de WiIt JH, Verheul HM. Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology. Curr Pharm Des 2006; 12: 2623-2630.
31. van der Pool AE, Lalmahomed ZS, de Wilt JH, Eggermont AM, Ijzermans JM, Verhoef C. Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy. J Gastrointest Surg 2009; 13: 890-895.